302 related articles for article (PubMed ID: 19333200)
1. Prevalence of antiphospholipid and antinuclear antibodies in children with epilepsy.
Constantin T; Kálovics T; Ponyi A; Nagy E; Sallai K; Szabó L; Garami M; Müller J; Gergely P; Dankó K; Fekete G; Kálmánchey R
Med Sci Monit; 2009 Apr; 15(4):CR164-9. PubMed ID: 19333200
[TBL] [Abstract][Full Text] [Related]
2. Frequency of anticardiolipin, antinuclear and anti-beta2 glycoprotein I antibodies in children with epilepsy.
Markić J; Mestrović M; Valić I; Sapunar A; Bosnjak N
Coll Antropol; 2007 Sep; 31(3):739-42. PubMed ID: 18041382
[TBL] [Abstract][Full Text] [Related]
3. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
Marie I; Jouen F; Hellot MF; Levesque H
Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496
[TBL] [Abstract][Full Text] [Related]
4. Real world experience with antiphospholipid antibody tests: how stable are results over time?
Erkan D; Derksen WJ; Kaplan V; Sammaritano L; Pierangeli SS; Roubey R; Lockshin MD
Ann Rheum Dis; 2005 Sep; 64(9):1321-5. PubMed ID: 15731290
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha.
Matsuda J; Saitoh N; Gotoh M; Gohchi K; Tsukamoto M; Syoji S; Miyake K; Yamanaka M
Am J Gastroenterol; 1995 Jul; 90(7):1138-41. PubMed ID: 7611213
[TBL] [Abstract][Full Text] [Related]
6. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome].
Ieko M; Nakabayashi T; Tarumi T; Yoshida M; Naito S; Atsumi T; Koike T
Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574
[TBL] [Abstract][Full Text] [Related]
7. Anti-beta2-glycoprotein I in childhood immune thrombocytopenic purpura.
El-Bostany EA; El-Ghoroury EA; El-Ghafar EA
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):26-31. PubMed ID: 18180612
[TBL] [Abstract][Full Text] [Related]
8. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
9. [Antiphospholipid antibodies with HCV infection. Innocent proteins or risk factor?].
Kisiel E; Kryczka W
Przegl Lek; 2007; 64(7-8):521-4. PubMed ID: 18409357
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome.
Ganor Y; Goldberg-Stern H; Blank M; Shoenfeld Y; Dobrynina LA; Kalashnikova L; Levite M
Autoimmunity; 2005 Sep; 38(6):417-24. PubMed ID: 16278146
[TBL] [Abstract][Full Text] [Related]
11. Study of antiphospholipid antibodies in patients treated with antiepileptic drugs.
Pardo A; González-Porque P; Gobernado JM; Jiménez-Escrig A; Lousa M
Neurologia; 2001 Jan; 16(1):7-10. PubMed ID: 11234666
[TBL] [Abstract][Full Text] [Related]
12. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
13. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
[TBL] [Abstract][Full Text] [Related]
14. Anticardiolipin, glutamic acid decarboxylase, and antinuclear antibodies in epileptic patients.
Verrotti A; Greco R; Altobelli E; Latini G; Morgese G; Chiarelli F
Clin Exp Med; 2003 May; 3(1):32-6. PubMed ID: 12748877
[TBL] [Abstract][Full Text] [Related]
15. Anticardiolipin and antinuclear antibodies in epilepsy--a population-based cross-sectional study.
Ranua J; Luoma K; Peltola J; Haapala AM; Raitanen J; Auvinen A; Isojärvi J
Epilepsy Res; 2004 Jan; 58(1):13-8. PubMed ID: 15066670
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura.
Pratt EL; Tarantino MD; Wagner D; Hirsch Pescovitz O; Bowyer S; Shapiro AD
Am J Hematol; 2005 Jul; 79(3):175-9. PubMed ID: 15981229
[TBL] [Abstract][Full Text] [Related]
17. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry.
Avcin T; Cimaz R; Silverman ED; Cervera R; Gattorno M; Garay S; Berkun Y; Sztajnbok FR; Silva CA; Campos LM; Saad-Magalhaes C; Rigante D; Ravelli A; Martini A; Rozman B; Meroni PL
Pediatrics; 2008 Nov; 122(5):e1100-7. PubMed ID: 18955411
[TBL] [Abstract][Full Text] [Related]
18. Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis.
Szmyrka-Kaczmarek M; Pokryszko-Dragan A; Pawlik B; Gruszka E; Korman L; Podemski R; Wiland P; Szechinski J
Lupus; 2012 Apr; 21(4):412-20. PubMed ID: 22074845
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical correlates of anti-phospholipid antibodies in South Africans with systemic lupus erythematosus.
Gould T; Tikly M; Asherson R; Loizou S; Singh S
Scand J Rheumatol; 2006; 35(1):29-34. PubMed ID: 16467038
[TBL] [Abstract][Full Text] [Related]
20. The prevalence and clinical significance of antiphospholipid antibodies in the patients with systemic sclerosis--preliminary report.
Sulik A; Kowal-Bielecka O; Domysławska I; Chwiećko J; Sierakowski S
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():228-31. PubMed ID: 16119673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
